Tech Review highlights a test from Adnavance that can detect methicillin-resistant Staphylococcus aureus without culturing the bacteria or amplifying the DNA. Instead, the Adnavance test is built on top of a gold electrode that is covered with a proprietary marker. The marker binds MRSA and when a current flows through the gold electrode, it attracts the DNA. CEO Randy White says they plan to launch the test in 2011 at a price of about $60.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.